MLXIPL and Hepatic steatosis: In HepG2 cells and mice, SIK2 inhibited p300 activity by direct phosphorylation, and therefore also decreased the lipogenesis mediated by ChREBP. SIK2 depletion caused an overexpression of p300 increasing lipogenesis and causing insulin resistance, hepatic steatosis and inflammation (54).